Alvogen agrees biosimilar commercial deals in three major markets
Biosimilar developer agrees three different distribution partners in South Korea, Israel and Canada for biosimilar to Forteo.
Archives for October 23, 2019
‘Never too early’ for patient engagement on ATMPs development, says ARM
Early dialogue with patients is ‘critical’ to design efficient clinical development programs for ATMPs and avoid ‘data gaps’, an executive from ARM says.
Novartis’ gene therapy beats sales estimates but held up by manufacturing questions
Novartis announces its third quarter results that show Zolgensma is outperforming sales expectations, but company notes approval in EU and Japan pushed back over manufacturing queries.